propionylcarnitine has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YH; Park, S | 1 |
| Alvarez de Sotomayor, M; Dolores Herrera, M; Gonzalez del Pozo, M; Mingorance, C | 1 |
2 other study(ies) available for propionylcarnitine and Metabolic Syndrome
| Article | Year |
|---|---|
Genetic and Lifestyle-Related Factors Influencing Serum Hyper-Propionylcarnitine Concentrations and Their Association with Metabolic Syndrome and Cardiovascular Disease Risk.
Topics: Aged; Amino Acids; Cardiovascular Diseases; Carnitine; Genome-Wide Association Study; Humans; Kinesins; Life Style; Metabolic Syndrome; Middle Aged; Risk Factors | 2023 |
Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
Topics: Animals; Carnitine; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Endothelium, Vascular; Glucose Tolerance Test; Hemodynamics; Hyperinsulinism; Insulin Resistance; Lipids; Metabolic Syndrome; Obesity; Rats; Rats, Zucker; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Weight Gain | 2009 |